USANA Health Sciences Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
USANA (USNA) PT Raised to $80 at Pivotal Research
October 25, 2017 12:30 PM EDTPivotal Research analyst Timothy Ramey raised his price target on USANA Health Sciences Inc. (NYSE: USNA) to $80.00 (from $70.00) while maintaining a Buy rating following better-than-expected Q3 EPS on 3% sales growth with F/X not a factor for the first time in three years.
Active... More
USANA Health Sciences (USNA) Tops Q3 EPS by 6c
October 24, 2017 4:17 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.97, $0.06 better than the analyst estimate of $0.91. Revenue for the quarter came in at $261.8 million versus the consensus estimate of $259.47 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
... More